Cargando…
Optimized furosemide taste masked orally disintegrating tablets
Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS;...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681311/ https://www.ncbi.nlm.nih.gov/pubmed/29158715 http://dx.doi.org/10.1016/j.jsps.2017.04.002 |
_version_ | 1783277895669514240 |
---|---|
author | Ibrahim, Mohamed Abbas Abou El Ela, Amal El Sayeh F. |
author_facet | Ibrahim, Mohamed Abbas Abou El Ela, Amal El Sayeh F. |
author_sort | Ibrahim, Mohamed Abbas |
collection | PubMed |
description | Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS; X2) on tablet properties. A composite was prepared by mixing ethanolic solution of FUR and Eudragit E100 with mannitol prior to mixing with other tablet ingredients. The prepared ODTs were characterized for their FUR content, hardness, friability and wetting time. The optimized ODT formulation (F1) was evaluated in term of palatability parameters and the in vivo disintegration. The manufactured ODTs were complying with the pharmacopeia guidelines regarding hardness, friability, weight variation and content. Eudragit E100 had a very slightly enhancing effect on tablets disintegration. However, the effects of both Eudragit E100 (X1) and CCS (X2) on ODTs disintegration time (Y1) were insignificant (p > 0.05). Moreover, X1 exhibited antagonistic effect on the dissolution after 5 and 30 min (D5 and D30, respectively), but only its effect on D30 is significant (p = 0.0004). Furthermore, the optimized ODTs formula showed good to acceptable taste in term of palatability, and in vivo disintegration time of this formula was about 10 s. |
format | Online Article Text |
id | pubmed-5681311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56813112017-11-20 Optimized furosemide taste masked orally disintegrating tablets Ibrahim, Mohamed Abbas Abou El Ela, Amal El Sayeh F. Saudi Pharm J Article Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS; X2) on tablet properties. A composite was prepared by mixing ethanolic solution of FUR and Eudragit E100 with mannitol prior to mixing with other tablet ingredients. The prepared ODTs were characterized for their FUR content, hardness, friability and wetting time. The optimized ODT formulation (F1) was evaluated in term of palatability parameters and the in vivo disintegration. The manufactured ODTs were complying with the pharmacopeia guidelines regarding hardness, friability, weight variation and content. Eudragit E100 had a very slightly enhancing effect on tablets disintegration. However, the effects of both Eudragit E100 (X1) and CCS (X2) on ODTs disintegration time (Y1) were insignificant (p > 0.05). Moreover, X1 exhibited antagonistic effect on the dissolution after 5 and 30 min (D5 and D30, respectively), but only its effect on D30 is significant (p = 0.0004). Furthermore, the optimized ODTs formula showed good to acceptable taste in term of palatability, and in vivo disintegration time of this formula was about 10 s. Elsevier 2017-11 2017-04-13 /pmc/articles/PMC5681311/ /pubmed/29158715 http://dx.doi.org/10.1016/j.jsps.2017.04.002 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Ibrahim, Mohamed Abbas Abou El Ela, Amal El Sayeh F. Optimized furosemide taste masked orally disintegrating tablets |
title | Optimized furosemide taste masked orally disintegrating tablets |
title_full | Optimized furosemide taste masked orally disintegrating tablets |
title_fullStr | Optimized furosemide taste masked orally disintegrating tablets |
title_full_unstemmed | Optimized furosemide taste masked orally disintegrating tablets |
title_short | Optimized furosemide taste masked orally disintegrating tablets |
title_sort | optimized furosemide taste masked orally disintegrating tablets |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681311/ https://www.ncbi.nlm.nih.gov/pubmed/29158715 http://dx.doi.org/10.1016/j.jsps.2017.04.002 |
work_keys_str_mv | AT ibrahimmohamedabbas optimizedfurosemidetastemaskedorallydisintegratingtablets AT abouelelaamalelsayehf optimizedfurosemidetastemaskedorallydisintegratingtablets |